These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7629186)

  • 1. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle.
    Busby TF; Argraves WS; Brew SA; Pechik I; Gilliland GL; Ingham KC
    J Biol Chem; 1995 Aug; 270(31):18558-62. PubMed ID: 7629186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin.
    Ingham KC; Brew SA; Migliorini MM; Busby TF
    Biochemistry; 1993 Nov; 32(46):12548-53. PubMed ID: 8241146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
    Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
    Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site.
    Zhong X; Arnolds O; Krenczyk O; Gajewski J; Pütz S; Herrmann C; Stoll R
    Biochemistry; 2018 Oct; 57(42):6045-6049. PubMed ID: 30260627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structural analysis of fibronectin heparin-binding domain mutations.
    Kapila Y; Doan D; Tafolla E; Fletterick R
    J Cell Biochem Suppl; 2001; Suppl 36():156-61. PubMed ID: 11455580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the NH2-terminal domain of fibronectin with heparin. Role of the omega-loops of the type I modules.
    Kishore R; Samuel M; Khan MY; Hand J; Frenz DA; Newman SA
    J Biol Chem; 1997 Jul; 272(27):17078-85. PubMed ID: 9202024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual heparin-binding peptide from the carboxy-terminal hep-2 region of fibronectin.
    Ingham KC; Brew SA; Migliorini M
    Arch Biochem Biophys; 1994 Oct; 314(1):242-6. PubMed ID: 7944402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of N-terminal fragments of fibronectin with synthetic and recombinant D motifs from its binding protein on Staphylococcus aureus studied using fluorescence anisotropy.
    Huff S; Matsuka YV; McGavin MJ; Ingham KC
    J Biol Chem; 1994 Jun; 269(22):15563-70. PubMed ID: 8195201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between fibronectin and chondroitin sulfate are modulated by molecular context.
    Barkalow FJ; Schwarzbauer JE
    J Biol Chem; 1994 Feb; 269(6):3957-62. PubMed ID: 8307950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C binds heparin by its fibronectin type III domain five.
    Weber P; Zimmermann DR; Winterhalter KH; Vaughan L
    J Biol Chem; 1995 Mar; 270(9):4619-23. PubMed ID: 7533163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin.
    Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL
    Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X.
    Lethias C; Elefteriou F; Parsiegla G; Exposito JY; Garrone R
    J Biol Chem; 2001 May; 276(19):16432-8. PubMed ID: 11278641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
    Wallon UM; Overall CM
    J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the ganglioside-binding site of fibronectin.
    Thompson LK; Horowitz PM; Bentley KL; Thomas DD; Alderete JF; Klebe RJ
    J Biol Chem; 1986 Apr; 261(11):5209-14. PubMed ID: 3957921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin.
    Benecky MJ; Kolvenbach CG; Amrani DL; Mosesson MW
    Biochemistry; 1988 Sep; 27(19):7565-71. PubMed ID: 3207688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin.
    Sachchidanand ; Lequin O; Staunton D; Mulloy B; Forster MJ; Yoshida K; Campbell ID
    J Biol Chem; 2002 Dec; 277(52):50629-35. PubMed ID: 12377765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
    Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A
    Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.